In vivo rectal dosimeter with MRI marker
Open Access
- 22 July 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354149
Abstract
Background: Hypofractionated external beam radiotherapy for prostate cancer necessitates precise rectal dose evaluation. We fabricated a radiochromic polyurethane-based in vivo rectal dosimeter with a custom MRI marker and a patient-specific applicator for in vivo dose verification (IDV) during gated MR-image guided radiotherapy (MR-IGRT). Methods: The dosimeter featured a radiochromic polyurethane active layer, incorporating leucomalachite green (LMG) and tartrazine. To accommodate anatomical variations, a detachable PMMA applicator was designed in five sizes. For localization, four elastomeric materials, including two polyurethane-based and two silicone-based materials, were evaluated as candidate MRI markers. Post-irradiation fading was assessed over time to evaluate measurement stability. A dose-response calibration was performed to establish a linear relationship between net optical density (OD) and absorbed dose. Furthermore, dose uncertainty was analyzed based on the law of error propagation. For verification, in vivo measurements were conducted for two patients and compared with TPS-calculated doses. Results: Vyta Flex 20 was selected as the optimal MRI marker due to its high signal intensity and ease of fabrication. Post-irradiation net OD showed a dose-dependent temporal response, and the readout time was standardized to 2 h. The dosimeter’s sensitivity was 0.00253 cGy -1 . Dose uncertainties were determined to be 2.1%, 2.0%, and 1.6% at 100, 200, and 300 cGy, respectively. In vivo verification showed mean dose differences of 3.7 ± 1.4% (95% CI, 0.1–7.3%) for patient #1 and 5.9 ± 2.1% (95% CI, 0.8–11.1%) for patient #2. Measured doses were consistently higher than TPS-calculated doses, suggesting possible contributions from localization uncertainty in high-dose-gradient regions and the material-dependent response of the radiochromic active layer. Conclusion: The fabricated radiochromic dosimeter with a custom MRI marker and adjustable applicator demonstrated preliminary feasibility as a proof-of-concept system for in vivo rectal dose verification during MR-IGRT. Further studies with larger patient cohorts and more treatment fractions are required to validate its reproducibility, statistical robustness, and clinical utility. Further refinement in positioning is also needed, particularly in dose-gradient regions.Keywords
Funding Information
- Ministry of Science and ICT, South Korea (2017R1C1B1006636)
- Ministry of Science and ICT, South Korea (RS-2025-00339804)
This publication has 23 references indexed in Scilit:
- Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gatingStrahlentherapie und Onkologie, 2022
- 3D in vivo dosimetry of HDR gynecological brachytherapy using micro silica bead TLDsJournal of Applied Clinical Medical Physics, 2022
- ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancerRadiotherapy and Oncology, 2019
- Evaluation of accuracy and precision in polymer gel dosimetryMedical Physics, 2017
- MRI-guided prostate adaptive radiotherapy – A systematic reviewRadiotherapy and Oncology, 2016
- Magnetic Resonance Imaging (MRI) Markers for MRI-Guided High-Dose-Rate Brachytherapy: Novel Marker-Flange for Cervical Cancer and Marker Catheters for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- An Endorectal Balloon Reduces Intrafraction Prostate Motion During RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of LifeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Prostate Planning Treatment Volume Margin Calculation Based on the ExacTrac X-Ray 6D Image-Guided System: Margins for Various Clinical ImplementationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007